Alexandre Huber
Impact in
- Aging top 2%
- Genetics, Aging, and Longevity in Model Organisms
- Molecular Biology top 10%
- Fungal and yeast genetics research
- PI3K/AKT/mTOR signaling in cancer
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- RNA modifications and cancer
Papers in
-
- Fungal and yeast genetics research 3
- PI3K/AKT/mTOR signaling in cancer 2
- RNA modifications and cancer 2
- RNA and protein synthesis mechanisms 1
- Oncology 2
- Co-authors
- Robbie Loewith (4 shared papers)Gustav Ammerer (2 shared papers)Dorothea Anrather (2 shared papers)Michael Ståhl (2 shared papers)Olivier Deloche (1 shared paper)Howard Riezman (1 shared paper)Soyeon I. Lippman (1 shared paper)Claudio De Virgilio (1 shared paper)
- Journals
- Molecular Cell (1 paper)Clinical Cancer Research (1 paper)Molecular Biology of the Cell (1 paper)Frontiers in Oncology (1 paper)The EMBO Journal (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Alexandre Huber
11 papers receiving 1.3k citations
Alexandre Huber's Hit Papers
Peers
Comparison fields: 5 of 75
- Aging 143
- Molecular Biology 1.1k
- Cell Biology 219
- Pharmacology 90
- Plant Science 183
Countries citing papers authored by Alexandre Huber
This map shows the geographic impact of Alexandre Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Huber more than expected).
Fields of papers citing papers by Alexandre Huber
This network shows the impact of papers produced by Alexandre Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Huber. The network helps show where Alexandre Huber may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexandre Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sch9 Is a Major Target of TORC1 in Saccharomyces cerevisiae Hit paper breakdown → | 2007 | 635 |
| 2 | 2009 | 269 | |
| 3 | 2007 | 176 | |
| 4 | 2011 | 132 | |
| 5 | 2015 | 69 | |
| 6 | 2016 | 19 | |
| 7 | 1994 | 12 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 8 | |
| 10 | 2000 | 8 | |
| 11 | 2022 | 3 |
About Alexandre Huber
Alexandre Huber is a scholar working on Molecular Biology, Oncology, Surgery, Genetics and Neurology, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include Fungal and yeast genetics research (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), RNA modifications and cancer (2 papers), RNA and protein synthesis mechanisms (1 paper), Bone fractures and treatments (1 paper), Orthopedic Surgery and Rehabilitation (1 paper), Glioma Diagnosis and Treatment (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Aging (143 citations), Molecular Biology (1.1k citations), Cell Biology (219 citations), Pharmacology (90 citations) and Plant Science (183 citations). Alexandre Huber has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Robbie Loewith, Gustav Ammerer, Dorothea Anrather, Michael Ståhl, Olivier Deloche, Howard Riezman, Soyeon I. Lippman, Claudio De Virgilio, Alexandre Soulard and James R. Broach. Their work appears in journals such as Molecular Cell, Clinical Cancer Research, Molecular Biology of the Cell, Frontiers in Oncology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.